ProMetic offers its state of the art technologies for large-scale purification of biologics, drug development, proteomics and the elimination of pathogens to a growing base of industry leaders.

ProMetic uses its own affinity technology that provides for highly efficient extraction and purification of therapeutic proteins from human plasma in order to develop best-in-class therapeutics and orphan drugs.

ProMetic is also active in developing its own novel small-molecule therapeutic products targeting unmet medical needs in the field of fibrosis, cancer and autoimmune diseases/inflammation.

 

2013 ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS

click here to listen

2013 ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS PRESENTATION

Click here to view the presentation

ProMetic BioProduction Corporate Video

Click here to view the video

 

Learn More »